Integrated anatomical and functional approach for tailored renal interventions-in patients with resistant arterial hypertension

Fezzi S, Castaldi G, Widmann M, Marin F, Ribichini F (2021) The return of renal denervation for the treatment of hypertension: an update on new evidence and clinical indications. G Ital Cardiol 22(3 Suppl 1):17S-24S Marin F, Fezzi S, Gambaro A, Ederle F, Castaldi G, Widmann M et al (2021) Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience. J Nephrol 34(5):1445–1455 Schmieder RE, Mahfoud F, Mancia G, Azizi M, Böhm M, Dimitriadis K et al (2021) European Society of Hypertension position paper on renal denervation 2021. J Hypertens 39(9):1733–1741 Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM et al (2014) Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 370(1):13–22 Mitchell JA, Subramanian R, White CJ, Soukas PA, Almagor Y, Stewart RE et al (2007) Predicting blood pressure improvement in hypertensive patients after renal artery stent placement: renal fractional flow reserve. Catheter Cardiovasc Interv 69(5):685–689 Ribichini F, Pighi M, Zivelonghi C, Gambaro A, Valvo E, Lupo A et al (2013) Invasive assessment of renal artery atherosclerotic disease and resistant hypertension before renal sympathetic denervation. J Nephrol 26(4):799–801 Radermacher J, Ellis S, Haller H (2002) Renal resistance index and progression of renal disease. Hypertension 39(2 Pt 2):699–703 Tanemoto M, Takeuchi Y, Mishima E, Suzuki T, Abe T, Ito S (2010) Stage of chronic kidney disease is an outcome-predicting factor of angioplasty for atheromatous renal artery stenosis. Hypertens Res 33(11):1206–1210 Mahfoud F, Mancia G, Schmieder R, Narkiewicz K, Ruilope L, Schlaich M et al (2020) Renal denervation in high-risk patients with hypertension. J Am Coll Cardiol 75(23):2879–2888